Cargando…
Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment
BACKGROUND: Subcutaneous or intravenous immunoglobulin replacement is the mainstay of treatment for most patients with primary immunodeficiency disease (PID). The purpose of this study was to gain an understanding of how existing PID therapies affect patient lives and to identify desired improvement...
Autores principales: | Espanol, Teresa, Prevot, Johan, Drabwell, Jose, Sondhi, Seema, Olding, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014377/ https://www.ncbi.nlm.nih.gov/pubmed/24833896 http://dx.doi.org/10.2147/PPA.S60771 |
Ejemplares similares
-
The Development of a New Questionnaire to Measure the Burden of Immunoglobulin Treatment in Patients with Primary Immunodeficiencies: The IgBoT-35
por: Jones, Georgina L, et al.
Publicado: (2020) -
Primary Immune Deficiencies – Principles of Care
por: Chapel, Helen, et al.
Publicado: (2014) -
Ensuring Access to Immunoglobulin Therapies for People with Primary Immunodeficiency: A Need to Improve Individuals’ Quality of Life and the Sustainability of Health-care Systems
por: Bousfiha, Ahmed Aziz, et al.
Publicado: (2017) -
Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
por: Jolles, Stephen
Publicado: (2013) -
Primary Immunodeficiencies: A Decade of Progress and a Promising Future
por: Meyts, Isabelle, et al.
Publicado: (2021)